JOIN NOW!

CPHL Stock Price and and Company Financials

Citi Pharma Ltd.

Price: Rs. 78.45 Rs. -0.05 (-0.06%)

Last updated: 2026-06-12
Share on Facebook

Annual Financials (Latest Year: 2025)

Sales
Rs. 13,153,521,000
Total revenue generated from core business operations during the year.
Profit After Tax
Rs. 892,039,000
Net earnings after all expenses, interest, and taxes – the "bottom line".
Earnings Per Share (EPS)
Rs. 3.90
Profit allocated to each share – higher EPS means better profitability per share.
Gross Profit Margin
15.34%
Percentage of revenue left after deducting cost of goods sold – shows production efficiency.
Net Profit Margin
6.78%
What percentage of revenue becomes actual profit after all expenses – a key profitability measure.
EPS Growth
6.85%
Year‑over‑year increase in earnings per share – indicates growing profitability.
Business Description:
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
*Annual figures from latest financial statement
Open Close Low High Volume
78.50 78.45 78.01 79.29 1,406,010
From: To:

Top Stocks Players

Based on 2026-06-12 data
View all stocks players
Player Profit
image AJ
Lahore 		+26.2%
image UDS idrees
RWP, Pakistan 		+14.7%
image akhtar 2012
Karachi 		+10.2%
image idrees barlas
Rawalpindi, Pakistan 		+10.1%
image Muhammad ghazanfar
Sargodha, Pakistan 		+9.1%
image kaly kachy wala
Gujranwala, Pakistan 		+6.4%
image G1F22UBSAF009
Gujranwala, Pakistan 		+5.6%
image Mukaram Bhatti
Gujranwala 		+4.5%
image Muhammad “raza” Zaidi
Karachi, Pakistan 		+4.3%
image G1F22UBSAF005
Gujranwala, Pakistan 		+3.3%